021-51111890
购物车（）
sales@molnova.cn
AVN-101
CAS No. 1025725-91-0
AVN-101 ( AVN101 )
产品货号. M10121 CAS No. 1025725-91-0
A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥7857 | 有现货 |
|
| 50MG | ￥16038 | 有现货 |
|
| 100MG | ￥20250 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称AVN-101
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM).
-
产品描述A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM); also exhibits a rather high affinity toward histamine H1 (Ki=0.58nM) and adrenergic α2A, α2B, and α2C (Ki=0.41-3.6nM) receptors; demonstrates reasonable anxiolytic and anti-depressive activities in animal models of CNS diseases with low safety concerns.Anxiety Phase 2 Clinical
-
同义词AVN101
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT Receptor
-
研究领域Neurological Disease
-
适应症Anxiety
化学信息
-
CAS Number1025725-91-0
-
分子量304.44
-
分子式C21H24N2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CC=CC=C4
-
化学全称2,8-dimethyl-5-phenethyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ivachtchenko AV, et al. J Alzheimers Dis. 2016 May 25;53(2):583-620.
产品手册
关联产品
-
Clomipramine hydroch...
Clomipramine HCl is a serotonin transporter (SERT).
-
6-fluoro-DL-Tryptoph...
6-fluoro-DL-Tryptophan is an inhibitor of serotonin (5-HT)?synthesis.
-
NGB2904 HCl
NGB2904 is a potent and selective antagonist of dopamine D3 receptor (Ki values are 1.4, 217, 223, 642, > 5000, > 10000 and > 10000 nM for D3, D2, 5-HT2, α1, D4, D1 and D5 receptors respectively).
